Cancer Genetics, Inc. Gains 49.05%

Wed, Feb 10, 2021 at 05:30 PM
Cancer Genetics, Inc. Gains 49.05%

Cancer Genetics, Inc. (CGIX:NASDAQ) soared at $8.6, a gain of 49%. On Tue 09 Feb 21, CGIX:NASDAQ hit a New 2-Week High of $5.77. The stock appeared on our News Catalysts scanner on Sat 06 Feb 21 at 01:03 PM in the 'INVESTOR UPDATE' category. From Tue 26 Jan 21, the stock recorded 40.00% Up Days and 36.36% Green Days

The stock spiked on Wed 20 Jan 21 at $5.95 with a volume of 8M+.

About Cancer Genetics, Inc. (CGIX:NASDAQ)

Cancer Genetics Inc is an early-stage diagnostics company which develops, commercializes and provides molecular- and biomarker-based tests and services that enable physicians to personalize the clinical management of each individual patient.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.